Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Rule 8.3- Computacenter PLC

16 Dec 2005 11:51

Aviva PLC16 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) AVIVA PLC AND ITS SUBSIDIARIESCompany dealt in COMPUTACENTER PLCClass of relevant security to which the dealings ORD GBP0.05being disclosed relate (Note 2)Date of dealing 15 DECEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 1,900,069 1.000% 0 0%(2) Derivatives (other than options) 0 0% 0 0%(3) Options and agreements to purchase/ 0 0% 0 0%sellTotal 1,900,069 1.000% 0 0% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities 0 0% 0 0%(2) Derivatives (other than options) 0 0% 0 0%(3) Options and agreements to purchase/sell 0 0% 0 0%Total 0 0% 0 0% (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5)PURCHASE 2,300 GBP2.538800 (b) Derivatives transactions (other than options) Product name, Long/short (Note Number of securities Price per unite.g. CFD 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which European receivedoption varying etc. the option etc. per unit relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 16 DECEMBER 2005Contact name NEIL WHITTAKERTelephone number 01603 684420If a connected EFM, name of offeree/offeror with N/Awhich connectedIf a connected EFM, state nature of connection N/A(Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20267:00 amRNSAcquisition of Government Acquisitions Inc
19th May 20262:00 pmRNSResult of AGM
8th May 20262:00 pmRNSDirector/PDMR Shareholding
28th Apr 20261:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSQ1 Trading Update – 24 April 2026
8th Apr 202610:00 amRNS2025 Annual Financial Report & Notice of 2026 AGM
27th Mar 202610:00 amRNSDirector/PDMR Shareholding
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results 2025
5th Feb 20261:00 pmRNSBlock Listing Interim Review
22nd Jan 20267:00 amRNSPre-Close Trading Update – 22 January 2026
8th Jan 20267:00 amRNSAcquisition of AgreeYa Solutions Inc
6th Nov 20251:00 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSDirectorate Change
5th Aug 20251:00 pmRNSBlock listing Interim Review
31st Jul 20255:00 pmRNSHolding(s) in Company
31st Jul 20254:30 pmRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSTrading Update – 28 July 2025
26th Jun 20253:00 pmRNSDirector/PDMR Shareholding
15th May 20255:00 pmRNSResult of AGM
13th May 20255:45 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSQ1 Trading Update
9th Apr 20252:30 pmRNS2024 Annual Financial Report & Notice of 2025 AGM
2nd Apr 20252:30 pmRNSDirector/PDMR Shareholding
28th Mar 202510:00 amRNSDirector/PDMR Shareholding
26th Mar 20252:00 pmRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results 2024
6th Feb 202510:00 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNSPre-Close Trading Update
9th Jan 20257:00 amRNSDirectorate Change
16th Dec 20247:00 amRNSDirectorate Change
7th Nov 20245:00 pmRNSDirector/PDMR Shareholding
1st Nov 202412:00 pmRNSTotal Voting Rights
30th Oct 20246:14 pmRNSTransaction in Own Shares
30th Oct 20242:00 pmRNSDirector/PDMR Shareholding
29th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20247:00 amRNSQ3 Trading Update – 28 October 2024
25th Oct 20245:33 pmRNSTransaction in Own Shares
24th Oct 202412:00 pmRNSCancellation of Shares held in Treasury
24th Oct 20249:30 amRNSQ3 Trading Update - Release Date
23rd Oct 20245:49 pmRNSTransaction in Own Shares
22nd Oct 20246:18 pmRNSTransaction in Own Shares
18th Oct 20245:49 pmRNSTransaction in Own Shares
17th Oct 20245:48 pmRNSTransaction in Own Shares
16th Oct 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.